You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

List of Excipients in API ritonavir


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing ritonavir

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
AbbVie Inc NORVIR ritonavir 0074-3333 ANHYDROUS DIBASIC CALCIUM PHOSPHATE
AbbVie Inc NORVIR ritonavir 0074-3333 COPOVIDONE K25-31
AbbVie Inc NORVIR ritonavir 0074-3333 HYDROXYPROPYL CELLULOSE
AbbVie Inc NORVIR ritonavir 0074-3333 HYPROMELLOSE
AbbVie Inc NORVIR ritonavir 0074-3333 POLYETHYLENE GLYCOL 3350
AbbVie Inc NORVIR ritonavir 0074-3333 POLYETHYLENE GLYCOL 400
AbbVie Inc NORVIR ritonavir 0074-3333 POLYSORBATE 80
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Get Started Free

Excipients in ANDA-approved (generic) drugs containing ritonavir

Company Ingredient NDC Excipient
West-Ward Pharmaceuticals Corp ritonavir 0054-0407 ANHYDROUS DIBASIC CALCIUM PHOSPHATE
West-Ward Pharmaceuticals Corp ritonavir 0054-0407 COPOVIDONE K25-31
West-Ward Pharmaceuticals Corp ritonavir 0054-0407 HYPROMELLOSE
West-Ward Pharmaceuticals Corp ritonavir 0054-0407 ISOPROPYL ALCOHOL
West-Ward Pharmaceuticals Corp ritonavir 0054-0407 POLYETHYLENE GLYCOL
West-Ward Pharmaceuticals Corp ritonavir 0054-0407 POLYSORBATE 80
West-Ward Pharmaceuticals Corp ritonavir 0054-0407 SILICON DIOXIDE
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Get Started Free

Detailed excipient profiles for ritonavir

Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE

Excipient focus: CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: COPOVIDONE

Excipient focus: COPOVIDONE K25-31

Excipient focus: DIBASIC CALCIUM PHOSPHATE DIHYDRATE

Excipient focus: HYDROXYPROPYL CELLULOSE

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2910

Excipient focus: HYPROMELLOSES

Excipient focus: ISOPROPYL ALCOHOL

Excipient focus: MANNITOL

Excipient focus: MICROCRYSTALLINE CELLULOSE 102

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 3350

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: POLYETHYLENE GLYCOL 6000

Excipient focus: POLYSORBATE 80

Excipient focus: POWDERED CELLULOSE

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM STEARYL FUMARATE

Excipient focus: SORBITAN MONOLAURATE

Excipient focus: STARCH, CORN

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
 NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links